Niche-based screening identifies small-molecule inhibitors of leukemia stem cells

Kimberly A. Hartwell(Whitehead Institute for Biomedical Research), Todd R. Golub(Broad Institute), Shrikanta Chattopadhyay(Broad Institute), Marcus Järås(Brigham and Women's Hospital), Thomas Kindler(University of Applied Sciences Mainz), Vlado Dančík, Sebastian Shterental(Brigham and Women's Hospital), Paul A. Clemons(Broad Institute), Fátima Al‐Shahrour(Broad Institute), Mingji Dai(Emory University), David J. Logan(Pfizer (United States)), Stuart L. Schreiber(Broad Institute), J. Erika Haydu(Brigham and Women's Hospital), Alison L. Stewart(Broad Institute), Rishi V. Puram(Brigham and Women's Hospital), Mildred Duvet(Broad Institute), Thomas P. Hasaka, Anne E. Carpenter(Broad Institute), Joshua A. Bittker, Christina Huang(Broad Institute), Joseph Negri(Broad Institute), Benjamin L. Ebert(Broad Institute), Nicola Tolliday(Broad Institute), Alykhan F. Shamji, Siddhartha Mukherjee(Columbia University Irving Medical Center), Zuzana Tóthová(Broad Institute), David T. Scadden, Andrew M. Stern(Broad Institute), Peter G. Miller(Broad Institute), David P. Steensma(Harvard University), Alissa R. Kahn(Memorial Sloan Kettering Cancer Center), Malcolm A.S. Moore(Memorial Sloan Kettering Cancer Center), Benito Muñoz(Broad Institute), Jae Hung Shieh(Memorial Sloan Kettering Cancer Center), Rajiv Narayan(Broad Institute), D. Gary Gilliland(Novartis (Switzerland)), Lisa P. Chu(Brigham and Women's Hospital)
Nature Chemical Biology
October 27, 2013
Cited by 110


Related Papers